[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100619275":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":12,"centralContacts":25,"locations":35,"responsibleParty":54,"collaborators":56,"id":60,"slug":61,"hasResults":62,"nctId":63,"briefTitle":64,"officialTitle":65,"acronym":66,"eligibilityCriteria":67,"healthyVolunteers":62,"sex":68,"minAge":69,"maxAge":12,"enrollmentInfo":70,"targetDuration":12,"studyType":73,"phases":74,"briefSummary":76,"conditions":77,"keywords":82,"overallStatus":38,"whyStopped":12,"lastUpdateSubmitDate":88,"lastUpdatePostDateStruct":89,"startDateStruct":92,"completionDateStruct":94,"leadSponsor":96,"locationsCount":97},{"fullName":5,"class":6},"University of Notre Dame","OTHER",[8,13],{"label":9,"type":10,"description":11,"interventionNames":12},"Treatment As Usual","NO_INTERVENTION","No intervention is administered. All participants in this study receive prescribed buprenorphine for opioid use disorder and may, related to this, receive behavioral intervention focused on medication adherence and preventing opioid relapse. Treatment As Usual refers to receiving this and no additional intervention.",null,{"label":14,"type":15,"description":16,"interventionNames":17},"Experimental: Brief opioid-informed alcohol treatment","EXPERIMENTAL","The brief opioid-informed alcohol treatment is based upon principles of Motivation Enhancement Therapy (MET) and Cognitive Behavioral Therapy (CBT) tailored to the needs of patients in opioid treatment. Delivered once per week for 4 weeks.",[18],"Behavioral: Brief opioid-informed alcohol treatment",[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":12},"BEHAVIORAL","Brief opioid-informed alcohol treatment","The brief opioid-informed alcohol treatment is based upon principles of Motivation Enhancement Therapy (MET) and Cognitive Behavioral Therapy (CBT) tailored to the needs of patients in opioid treatment. Participants will attend weekly in-person sessions for four weeks.",[14],[26,31],{"name":27,"role":28,"phone":29,"phoneExt":12,"email":30},"Ryan Carpenter, PhD","CONTACT","+1 574-631-5429","ryancarpenter@nd.edu",{"name":32,"role":28,"phone":33,"phoneExt":12,"email":34},"Beth A Arnold, M.S.","574-213-2096","bhanawal@nd.edu",[36],{"facility":37,"status":38,"city":39,"state":40,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"The University of Notre Dame","RECRUITING","Notre Dame","Indiana","46556","United States","US",{"type":45,"coordinates":46},"Point",[47,48],-86.23793,41.70019,{"lat":48,"lon":47},[51,52],{"name":32,"role":28,"phone":33,"phoneExt":12,"email":34},{"name":27,"role":53,"phone":12,"phoneExt":12,"email":12},"PRINCIPAL_INVESTIGATOR",{"type":55,"investigatorFullName":12,"investigatorTitle":12,"investigatorAffiliation":12,"oldNameTitle":12,"oldOrganization":12},"SPONSOR",[57],{"name":58,"class":59},"National Institute on Alcohol Abuse and Alcoholism (NIAAA)","NIH","100619275","better-experiences-in-substance-treatment-a-brief-alcohol-focused-intervention-tailored-for-patients-in-opioid-agonist-treatment-100619275",false,"NCT07342504","Better Experiences in Substance Treatment: A Brief Alcohol-focused Intervention Tailored for Patients in Opioid Agonist Treatment","Better Experiences in Substance Treatment: A Brief Alcohol-Focused Intervention Tailored for Patients in Opioid Agonist Treatment","Project BEST","Inclusion Criteria for the RCT:\n\n* Participants must be taking prescribed buprenorphine for at least 2 weeks\n* Participants must be 18 years or older.\n* Meet DSM-5 criteria for alcohol use disorder (AUD)\n* Participants must report alcohol use ≥ 1 day\u002Fweek on average in the past 28 days\n* Participants must be able to read simple English\n\nExclusion Criteria:\n\n* Currently receiving formal alcohol use treatment.\n* Currently experiencing psychosis","ALL","18 Years",{"count":71,"type":72},60,"ESTIMATED","INTERVENTIONAL",[75],"NA","This study will help determine the feasibility and acceptability of a brief opioid-informed alcohol intervention in patients receiving prescribed buprenorphine for opioid use who are currently drinking alcohol. It will also provide initial information on whether the intervention improves outcomes related to alcohol use. The results of this proof-of-concept study will inform whether a future larger clinical trial is warranted.",[78,79,80,81],"Alcohol Use Disorder","Opioid Use Disorder","Alcohol Use","Opioid Use",[78,83,84,79,85,86,87],"Alcohol Use Disorder (AUD)","Cognitive Behavioral Therapy","Opioid Use Disorder (OUD)","Motivational Enhancement Therapy","Cognitive Behavior Therapy (CBT)","2026-06-05",{"date":90,"type":91},"2026-06-09","ACTUAL",{"date":93,"type":91},"2026-03-24",{"date":95,"type":72},"2027-03-01",{"name":5,"class":6},1]